Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 559

1.

WITHDRAWN: Diuretics for heart failure.

Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ.

Cochrane Database Syst Rev. 2016 Apr 4;4:CD003838. doi: 10.1002/14651858.CD003838.pub4. Review. No abstract available.

2.

Central and peripheral quadriceps fatigue in congestive heart failure.

Hopkinson NS, Dayer MJ, Antoine-Jonville S, Swallow EB, Porcher R, Vazir A, Poole-Wilson P, Polkey MI.

Int J Cardiol. 2013 Sep 10;167(6):2594-9. doi: 10.1016/j.ijcard.2012.06.064. Epub 2012 Jul 13.

3.

Diuretics for heart failure.

Faris RF, Flather M, Purcell H, Poole-Wilson PA, Coats AJ.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003838. doi: 10.1002/14651858.CD003838.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD003838.

PMID:
22336795
4.

Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

von Haehling S, Schefold JC, Jankowska EA, Springer J, Vazir A, Kalra PR, Sandek A, Fauler G, Stojakovic T, Trauner M, Ponikowski P, Volk HD, Doehner W, Coats AJ, Poole-Wilson PA, Anker SD.

J Am Coll Cardiol. 2012 Feb 7;59(6):585-92. doi: 10.1016/j.jacc.2011.10.880.

5.

Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: evidence of an immune basis.

Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY.

Int J Cardiol. 2013 Jul 1;166(3):664-71. doi: 10.1016/j.ijcard.2011.11.081. Epub 2011 Dec 20.

PMID:
22192286
6.

Cardiothoracic ratio from postero-anterior chest radiographs: a simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease.

Dimopoulos K, Giannakoulas G, Bendayan I, Liodakis E, Petraco R, Diller GP, Piepoli MF, Swan L, Mullen M, Best N, Poole-Wilson PA, Francis DP, Rubens MB, Gatzoulis MA.

Int J Cardiol. 2013 Jun 20;166(2):453-7. doi: 10.1016/j.ijcard.2011.10.125. Epub 2011 Dec 1.

PMID:
22137450
7.

Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study.

Saxena A, Ramakrishnan S, Roy A, Seth S, Krishnan A, Misra P, Kalaivani M, Bhargava B, Flather MD, Poole-Wilson PP.

Heart. 2011 Dec;97(24):2018-22. doi: 10.1136/heartjnl-2011-300792. Epub 2011 Nov 10.

PMID:
22076022
8.

Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.

Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA.

J Am Coll Cardiol. 2011 Sep 13;58(12):1241-51. doi: 10.1016/j.jacc.2011.04.040.

9.

Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology.

Assomull RG, Shakespeare C, Kalra PR, Lloyd G, Gulati A, Strange J, Bradlow WM, Lyne J, Keegan J, Poole-Wilson P, Cowie MR, Pennell DJ, Prasad SK.

Circulation. 2011 Sep 20;124(12):1351-60. doi: 10.1161/CIRCULATIONAHA.110.011346. Epub 2011 Sep 6.

10.

Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction.

Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY.

Int J Cardiol. 2013 Apr 15;164(3):359-64. doi: 10.1016/j.ijcard.2011.07.045. Epub 2011 Aug 6.

PMID:
21821297
11.

Predictors of clinical outcomes in elderly patients with heart failure.

Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S, van Veldhuisen DJ, Cohen-Solal A, Coats AJ, Poole-Wilson PP, Flather MD; SENIORS Investigators.

Eur J Heart Fail. 2011 May;13(5):528-36. doi: 10.1093/eurjhf/hfr030. Epub 2011 Mar 30.

12.

SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.

Lyon AR, Bannister ML, Collins T, Pearce E, Sepehripour AH, Dubb SS, Garcia E, O'Gara P, Liang L, Kohlbrenner E, Hajjar RJ, Peters NS, Poole-Wilson PA, Macleod KT, Harding SE.

Circ Arrhythm Electrophysiol. 2011 Jun;4(3):362-72. doi: 10.1161/CIRCEP.110.961615. Epub 2011 Mar 15.

13.

Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure.

Jankowska EA, Drohomirecka A, Ponikowska B, Witkowska A, Lopuszanska M, Szklarska A, Borodulin-Nadzieja L, Banasiak W, Poole-Wilson PA, Ponikowski P.

Eur J Heart Fail. 2010 Sep;12(9):966-73. doi: 10.1093/eurjhf/hfq108. Epub 2010 Jun 30.

14.

Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal.

Patel H, Ozdemir BA, Patel M, Xiao HB, Poole-Wilson PA, Rosen SD.

Int J Cardiol. 2011 Aug 18;151(1):34-9. doi: 10.1016/j.ijcard.2010.04.054. Epub 2010 May 18.

PMID:
20483183
15.

Gender differences in cardiac remodeling and clinical outcomes in chronic stable angina pectoris (from the ACTION Trial).

Ky B, Kirwan BA, de Brouwer S, Lubsen J, Poole-Wilson P, Otterstad JE, Kimmel SE, St John Sutton M.

Am J Cardiol. 2010 Apr 1;105(7):943-7. doi: 10.1016/j.amjcard.2009.11.019. Epub 2010 Feb 13.

PMID:
20346310
16.

Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease.

Dimopoulos K, Diller GP, Petraco R, Koltsida E, Giannakoulas G, Tay EL, Best N, Piepoli MF, Francis DP, Poole-Wilson PA, Gatzoulis MA.

Eur Heart J. 2010 Mar;31(5):595-601. doi: 10.1093/eurheartj/ehp495. Epub 2009 Nov 23.

PMID:
19933692
17.

Anemia in adults with congenital heart disease relates to adverse outcome.

Dimopoulos K, Diller GP, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis MA.

J Am Coll Cardiol. 2009 Nov 24;54(22):2093-100. doi: 10.1016/j.jacc.2009.06.050.

18.

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators.

Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16. Erratum in: Lancet. 2009 Dec 5;374(9705):1888.

PMID:
19922995
19.

Ferric carboxymaltose in patients with heart failure and iron deficiency.

Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators.

N Engl J Med. 2009 Dec 17;361(25):2436-48. doi: 10.1056/NEJMoa0908355. Epub 2009 Nov 17.

20.

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.

Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Mori C, von Eisenhart Rothe B, Pocock S, Poole-Wilson PA, Ponikowski P; FAIR-HF committees and investigators.

Eur J Heart Fail. 2009 Nov;11(11):1084-91. doi: 10.1093/eurjhf/hfp140.

21.

Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.

Boman K, Jansson JH, Nilsson T, Swedberg K, Cleland JG, Poole-Wilson P.

Thromb Res. 2010 Feb;125(2):e46-50. doi: 10.1016/j.thromres.2009.08.010. Epub 2009 Sep 16.

PMID:
19762071
22.

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.

Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH.

Circulation. 2009 Sep 8;120(10):835-42. doi: 10.1161/CIRCULATIONAHA.108.816884. Epub 2009 Aug 24.

23.

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.

Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR; ESSENTIAL Investigators.

Eur Heart J. 2009 Dec;30(24):3015-26. doi: 10.1093/eurheartj/ehp338.

24.

Optimism derived from 7.5 years of continuous-flow circulatory support.

Westaby S, Banning A, Neil D, Poole-Wilson P, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Mar;139(3):e45-7. doi: 10.1016/j.jtcvs.2008.05.072. Epub 2009 Mar 17. No abstract available.

25.

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M; SENIORS Investigators.

Eur J Heart Fail. 2009 Sep;11(9):872-80. doi: 10.1093/eurjhf/hfp104. Epub 2009 Aug 1.

26.

Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.

von Haehling S, Schefold JC, Jankowska E, Doehner W, Springer J, Strohschein K, Genth-Zotz S, Volk HD, Poole-Wilson P, Anker SD.

PLoS One. 2009 Jul 29;4(7):e6411. doi: 10.1371/journal.pone.0006411.

27.

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).

van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD; SENIORS Investigators.

J Am Coll Cardiol. 2009 Jun 9;53(23):2150-8. doi: 10.1016/j.jacc.2009.02.046.

28.

Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.

Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P.

J Card Fail. 2009 Jun;15(5):442-50. doi: 10.1016/j.cardfail.2008.12.011. Epub 2009 Feb 10.

PMID:
19477405
29.

C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure.

Kalra PR, Clague JR, Coats AJ, Anker SD, Poole-Wilson PA, Struthers AD.

Clin Sci (Lond). 2009 Oct 2;118(1):71-7. doi: 10.1042/CS20090092.

PMID:
19450232
30.

Circulating estradiol and mortality in men with systolic chronic heart failure.

Jankowska EA, Rozentryt P, Ponikowska B, Hartmann O, Kustrzycka-Kratochwil D, Reczuch K, Nowak J, Borodulin-Nadzieja L, Polonski L, Banasiak W, Poole-Wilson PA, Anker SD, Ponikowski P.

JAMA. 2009 May 13;301(18):1892-901. doi: 10.1001/jama.2009.639.

PMID:
19436016
31.

Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.

Levy WC, Mozaffarian D, Linker DT, Kenyon KW, Cleland JG, Komajda M, Remme WJ, Torp-Pedersen C, Metra M, Poole-Wilson PA; COMET Investigators.

Eur J Heart Fail. 2009 Mar;11(3):256-63. doi: 10.1093/eurjhf/hfn048. Epub 2009 Jan 22.

32.

Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants.

Jankowska EA, Jakubaszko J, Cwynar A, Majda J, Ponikowska B, Kustrzycka-Kratochwil D, Reczuch K, Borodulin-Nadzieja L, Banasiak W, Poole-Wilson PA, Ponikowski P.

Eur J Heart Fail. 2009 Jan;11(1):28-38. doi: 10.1093/eurjhf/hfn004.

33.

Global differences in the outcome of heart failure: implications for clinical practice.

Poole-Wilson PA.

J Am Coll Cardiol. 2008 Nov 11;52(20):1649-51. doi: 10.1016/j.jacc.2008.08.022. No abstract available.

34.

Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease.

Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, O'Hagan P, Montalescot G, Ballantyne CM, Cannon CP.

Am Heart J. 2008 Oct;156(4):719-27. doi: 10.1016/j.ahj.2008.05.020. Epub 2008 Jul 11.

PMID:
18926153
35.

Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.

Vokó Z, Danchin N, de Brouwer S, Kirwan BA, Poole-Wilson PA, Lubsen J; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators.

Int J Cardiol. 2010 Jan 7;138(1):56-62. doi: 10.1016/j.ijcard.2008.08.036. Epub 2008 Oct 8.

PMID:
18845347
36.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG).

Eur J Heart Fail. 2008 Oct;10(10):933-89. doi: 10.1016/j.ejheart.2008.08.005. Epub 2008 Sep 16. Review. No abstract available. Erratum in: Eur J Heart Fail. 2009 Jan;11(1):110. Eur J Heart Fail. 2010 Apr;12(4):416. Dosage error in article text.

37.

Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study.

Hastings PC, Vazir A, Meadows GE, Dayer M, Poole-Wilson PA, McIntyre HF, Morrell MJ, Cowie MR, Simonds AK.

Int J Cardiol. 2010 Feb 18;139(1):17-24. doi: 10.1016/j.ijcard.2008.08.022. Epub 2008 Sep 20.

PMID:
18805598
38.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG).

Eur Heart J. 2008 Oct;29(19):2388-442. doi: 10.1093/eurheartj/ehn309. Epub 2008 Sep 17. Review. No abstract available. Erratum in: Eur Heart J. 2010 Apr;12(4):416. Dosage error in article text. Eur Heart J. 2010 Mar;31(5):624. Dosage error in article text.

PMID:
18799522
39.

Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.

Yao G, Freemantle N, Flather M, Tharmanathan P, Coats A, Poole-Wilson PA; SENIORS Investigators.

Pharmacoeconomics. 2008;26(10):879-89.

PMID:
18793034
40.

Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor.

Konstam MA, Poole-Wilson PA, Dickstein K, Drexler H, Justice SJ, Komajda M, Malbecq W, Martinez FA, Neaton JD, Riegger GA, Guptha S.

Eur J Heart Fail. 2008 Sep;10(9):899-906. doi: 10.1016/j.ejheart.2008.07.004. Epub 2008 Sep 2.

41.

Resolution of central sleep apnoea following implantation of a left ventricular assist device.

Vazir A, Hastings PC, Morrell MJ, Pepper J, Henein MY, Westaby S, Poole-Wilson PA, Cowie MR, Simonds AK.

Int J Cardiol. 2010 Feb 4;138(3):317-9. doi: 10.1016/j.ijcard.2008.06.072. Epub 2008 Aug 26.

PMID:
18752859
42.

BetaAdrenoceptor blockade in congestive heart failure: future perspectives.

Poole-Wilson P.

Heart. 1998 Jun;79(Suppl 2):S35-6. No abstract available.

43.

Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.

Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA.

Circulation. 2008 May 6;117(18):2320-8. doi: 10.1161/CIRCULATIONAHA.107.734921. Epub 2008 Apr 28.

PMID:
18443238
44.

Rheumatic fever: the potential advantages of technology.

Poole-Wilson PA, Seth S.

Nat Clin Pract Cardiovasc Med. 2008 Jul;5(7):426-7. doi: 10.1038/ncpcardio1216. Epub 2008 Apr 15.

PMID:
18414451
45.

Variation in severity and type of sleep-disordered breathing throughout 4 nights in patients with heart failure.

Vazir A, Hastings PC, Papaioannou I, Poole-Wilson PA, Cowie MR, Morrell MJ, Simonds AK.

Respir Med. 2008 Jun;102(6):831-9. doi: 10.1016/j.rmed.2008.01.015. Epub 2008 Mar 17.

46.

Differences in European and North American approaches to the management of heart failure.

Poole-Wilson PA.

Cardiol Clin. 2008 Feb;26(1):107-12, viii. doi: 10.1016/j.ccl.2007.12.015. Review.

PMID:
18312910
47.

Chronic heart failure.

Poole-Wilson PA.

Timely Top Med Cardiovasc Dis. 2007 Jan 1;11:E2. No abstract available.

PMID:
18297148
48.

Focus on mechanical assist devices for the treatment of heart failure.

Poole-Wilson PA.

Nat Clin Pract Cardiovasc Med. 2008 Feb;5(2):59. doi: 10.1038/ncpcardio1114. No abstract available.

PMID:
18223539
49.

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P.

J Am Coll Cardiol. 2008 Jan 15;51(2):103-12. doi: 10.1016/j.jacc.2007.09.036.

50.

Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.

Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE.

Nat Clin Pract Cardiovasc Med. 2008 Jan;5(1):22-9. Review.

PMID:
18094670

Supplemental Content

Loading ...
Support Center